DIO2 and cancer: In addition, our bioinformatic analyses are mostly focused on DIO2 gene and mRNA assessment in cancer; however, it is widely demonstrated that the D2 enzymatic activity is subjected to a very complex post-transcriptional regulation and that DIO2 mRNA levels do not perfectly mirror the activity profile, thus additional studies will be essential to validate the D2 protein as a cancer biomarker.